Halaven

Halaven

Marketed minn: Eisai GmbH
Ingredjent attiv: Eribulin

Disponibbli fi: Unjoni Ewropea
Lingwa: Malti
Sors: EMA - European Medicines Agency

Harvoni

Harvoni

Marketed minn: Gilead Sciences Ireland UC
Ingredjent attiv: ledipasvir 90 mg, sofosbuvir 400 mg

Disponibbli fi: Unjoni Ewropea
Lingwa: Malti
Sors: EMA - European Medicines Agency

Hbvaxpro

Hbvaxpro

Marketed minn: MSD VACCINS
Ingredjent attiv: epatite B, antiġen tal-wiċċ rikombinanti

Disponibbli fi: Unjoni Ewropea
Lingwa: Malti
Sors: EMA - European Medicines Agency

Helicobacter Test Infai

Helicobacter Test Infai

Marketed minn: INFAI, Institut für biomedizinische Analytik NMR-Imaging GmbH
Ingredjent attiv: 13C-urea

Disponibbli fi: Unjoni Ewropea
Lingwa: Malti
Sors: EMA - European Medicines Agency

Helixate Nexgen

Helixate Nexgen

Marketed minn: Bayer AG 
Ingredjent attiv: octocog alfa

Disponibbli fi: Unjoni Ewropea
Lingwa: Malti
Sors: EMA - European Medicines Agency

Hemangiol

Hemangiol

Marketed minn: Pierre Fabre Dermatologie
Ingredjent attiv: propranolol hydrochloride

Disponibbli fi: Unjoni Ewropea
Lingwa: Malti
Sors: EMA - European Medicines Agency

Hepsera

Hepsera

Marketed minn: Gilead Sciences Ireland UC
Ingredjent attiv: adefovir dipivoxil

Disponibbli fi: Unjoni Ewropea
Lingwa: Malti
Sors: EMA - European Medicines Agency

Herceptin

Herceptin

Marketed minn: Roche Registration GmbH
Ingredjent attiv: trastuzumab

Disponibbli fi: Unjoni Ewropea
Lingwa: Malti
Sors: EMA - European Medicines Agency

Hetlioz

Hetlioz

Marketed minn: Vanda Pharmaceuticals Germany GmbH
Ingredjent attiv: tasimelteon

Disponibbli fi: Unjoni Ewropea
Lingwa: Malti
Sors: EMA - European Medicines Agency

Hexacima

Hexacima

Marketed minn: Sanofi Pasteur
Ingredjent attiv: toxoid tad-difterite / toxoid tat-tetnu, iż-żewġ-komponent tal-pertussis aċellulari (toxoid tal-pertussis u l-filamentużi haemagglutinin ) / poljomelite inattivat tal-virus tipi 1,2 u 3 / Haemophilus influenzae tat-tip b polysaccharide (polyribosylribitol phosphate) konjugat għall-proteina tat-tetnu, l-epatite B-antiġen tal-wiċċ

Disponibbli fi: Unjoni Ewropea
Lingwa: Malti
Sors: EMA - European Medicines Agency

Hexyon

Hexyon

Marketed minn: Sanofi Pasteur Europe
Ingredjent attiv: toxoid tad-difterite adsorbit fuq aluminium hydroxide, idratat, filamentużi haemagglutinin, Haemophilus influenzae tat-tip B polysaccharide (polyribosylribitol phosphate), l-epatite B-antiġen tal-wiċċ, toxoid tal-pertussis, poliovirus (inattivat) tip 1 (razza Mahoney) prodotta fuq ċelluli Vero, poliovirus (inattivat) tip 2 (MEF-1 razza) prodotta fuq ċelluli Vero, poliovirus (inattivat) tip 3 (razza Saukett) prodotta fuq ċelluli Vero, proteina tat-tetnu, adsorbit toxoid tat-tetnu fuq aluminium hydroxide, idr

Disponibbli fi: Unjoni Ewropea
Lingwa: Malti
Sors: EMA - European Medicines Agency

Hirobriz Breezhaler

Hirobriz Breezhaler

Marketed minn: Novartis Europharm Limited
Ingredjent attiv: indacaterol maleate

Disponibbli fi: Unjoni Ewropea
Lingwa: Malti
Sors: EMA - European Medicines Agency

Hizentra

Hizentra

Marketed minn: CSL Behring GmbH
Ingredjent attiv: immunoglobulina normali umana (SCIg)

Disponibbli fi: Unjoni Ewropea
Lingwa: Malti
Sors: EMA - European Medicines Agency

Holoclar

Holoclar

Marketed minn: Chiesi Farmaceutici S.p.A.
Ingredjent attiv: ex vivo espanda ċelloli umani awtoloġiċi kornea epithelial li jkun fih iċ-ċelloli staminali

Disponibbli fi: Unjoni Ewropea
Lingwa: Malti
Sors: EMA - European Medicines Agency

Humalog

Humalog

Marketed minn: Eli Lilly Nederland B.V.
Ingredjent attiv: insulina lispro

Disponibbli fi: Unjoni Ewropea
Lingwa: Malti
Sors: EMA - European Medicines Agency

Humenza

Humenza

Marketed minn: Sanofi Pasteur S.A.
Ingredjent attiv: qasma-virus tal-influwenza, inattivat, li fih antiġen*:/California/7/2009 (H1N1)v like strain (X-179A)*propagati fil-bajd.

Disponibbli fi: Unjoni Ewropea
Lingwa: Malti
Sors: EMA - European Medicines Agency

Humira

Humira

Marketed minn: AbbVie Deutschland GmbH Co. KG
Ingredjent attiv: adalimumab

Disponibbli fi: Unjoni Ewropea
Lingwa: Malti
Sors: EMA - European Medicines Agency

Hycamtin

Hycamtin

Marketed minn: Novartis Europharm Limited
Ingredjent attiv: topotecan

Disponibbli fi: Unjoni Ewropea
Lingwa: Malti
Sors: EMA - European Medicines Agency

Hyqvia

Hyqvia

Marketed minn: Baxalta Innovations GmbH
Ingredjent attiv: L-immunoglobulina normali umana

Disponibbli fi: Unjoni Ewropea
Lingwa: Malti
Sors: EMA - European Medicines Agency

Halagon

Halagon

Marketed minn: Emdoka BVBA
Ingredjent attiv: halofuginone lactate

Disponibbli fi: Unjoni Ewropea
Lingwa: Malti
Sors: EMA - European Medicines Agency

Halocur

Halocur

Marketed minn: Intervet International BV
Ingredjent attiv: halofuginone

Disponibbli fi: Unjoni Ewropea
Lingwa: Malti
Sors: EMA - European Medicines Agency

Hiprabovis Ibr Marker Live

Hiprabovis Ibr Marker Live

Marketed minn: Laboratorios Hipra S.A
Ingredjent attiv: virus ħaj tal-virus tal-herpes tal-ifrat imħallat b'ġenet doppju tip 1, razza CEDDEL: 106.3-107.3 CCID50

Disponibbli fi: Unjoni Ewropea
Lingwa: Malti
Sors: EMA - European Medicines Agency

Hemlibra

Hemlibra

Marketed minn: Roche Registration Limited
Ingredjent attiv: Emicizumab

Disponibbli fi: Unjoni Ewropea
Lingwa: Malti
Sors: EMA - European Medicines Agency

Halimatoz

Halimatoz

Marketed minn: Sandoz GmbH
Ingredjent attiv: adalimumab

Disponibbli fi: Unjoni Ewropea
Lingwa: Malti
Sors: EMA - European Medicines Agency

Hefiya

Hefiya

Marketed minn: Sandoz GmbH
Ingredjent attiv: adalimumab

Disponibbli fi: Unjoni Ewropea
Lingwa: Malti
Sors: EMA - European Medicines Agency

Hyrimoz

Hyrimoz

Marketed minn: Sandoz GmbH
Ingredjent attiv: adalimumab

Disponibbli fi: Unjoni Ewropea
Lingwa: Malti
Sors: EMA - European Medicines Agency

Herzuma

Herzuma

Marketed minn: Celltrion Healthcare Hungary Kft.
Ingredjent attiv: trastuzumab

Disponibbli fi: Unjoni Ewropea
Lingwa: Malti
Sors: EMA - European Medicines Agency

Hulio

Hulio

Marketed minn: Mylan S.A.S.
Ingredjent attiv: adalimumab

Disponibbli fi: Unjoni Ewropea
Lingwa: Malti
Sors: EMA - European Medicines Agency